Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Indication
Treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.
Therapeutic Area
Gastro-intestinal system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
100mg powder for concentrate solution for infusion
Comments
February 2015 - NICE MTA Advice: SMC Advice 374/07 is superseded by NICE TA329. November 2019 - Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines.
Link to Advice
Advice Published
25/02/2015